198 related articles for article (PubMed ID: 8771673)
21. [Effects of climatic treatment in the Bairam-Ali sanatorium on the course of chronic glomerulonephritis].
Khudaĭbergenov MA; Charyev MCh
Ter Arkh; 1987; 59(8):40-3. PubMed ID: 2961099
[TBL] [Abstract][Full Text] [Related]
22. [Specific features of a course of chronic glomerulonephritis with onset in childhood].
Shishkin AN; Makarova IuA; Erman MV
Ter Arkh; 2007; 79(6):52-6. PubMed ID: 17684968
[TBL] [Abstract][Full Text] [Related]
23. [Factors influencing the results of chronic glomerulonephritis treatment].
Riabov SI; Stavskaia VV; Chistova EK; Ashkinazi RI; Zaitseva NI; Kravchenko NP; Mozgovaia AN; Sashurina SN
Klin Med (Mosk); 1997; 75(2):38-42. PubMed ID: 9157214
[TBL] [Abstract][Full Text] [Related]
24. [Morphological characteristics of chronic glomerulonephritis with the nephrotic variant of the disease course].
Taran EI
Vrach Delo; 1987 Jul; (7):67-70. PubMed ID: 3630127
[No Abstract] [Full Text] [Related]
25. [The role of smooth muscle alpha-actin in development of renal fibrosis in patients with chronic glomerulonephritis].
Chebotareva NV; Bobkova IN; Varshavskiĭ VA; Golitsyna EP; Kozlovskaia LV
Ter Arkh; 2006; 78(5):17-21. PubMed ID: 16889044
[TBL] [Abstract][Full Text] [Related]
26. [Index of histopathological changes in rapidly progressive glomerulonephritis: a preliminary report].
Roszkowska-Blaim M; Mizerska-Wasiak M; Małdyk J; Weglarska J; Fiejka E
Pol Merkur Lekarski; 2000 Apr; 8(46):291-2. PubMed ID: 10897657
[TBL] [Abstract][Full Text] [Related]
27. [Treatment of various clinico-morphological variants of chronic glomerulonephritis].
Tomilina NA; Biriukova LS; Makurov AI; Ratner MIa
Ter Arkh; 1983; 55(6):61-6. PubMed ID: 6612622
[No Abstract] [Full Text] [Related]
28. [Morphological basis for the classification of clinical forms of chronic glomerulonephritis].
Ratner MIa; Serov VV
Klin Med (Mosk); 1971 Aug; 49(8):16-22. PubMed ID: 5127453
[No Abstract] [Full Text] [Related]
29. [Association of the complex of polymorphic markers of ACE genes, aldosteron synthetase and endothelial synthetase of nitric oxide with progression of chronic glomerulonephritis].
Kamysheva ES; Kutyrina IM; Nosikov VV; Shvetsov MIu; Gorashko NM; Ignat'ev IV; Voron'ko OE; Shilo VIu; Aliaev IuG; Shilov EM
Ter Arkh; 2004; 76(9):16-20. PubMed ID: 15532370
[TBL] [Abstract][Full Text] [Related]
30. [Sandimmun in the treatment of chronic glomerulonephritis with the nephrotic syndrome].
Krasnova TN; Tareeva IE; Shilov EM; Mukhin NA; Miroshnichenko NG
Ter Arkh; 1997; 69(6):21-3. PubMed ID: 9297266
[TBL] [Abstract][Full Text] [Related]
31. [Further study of the indications for combination cytostatic-anticoagulant-antiaggregation-corticosteroid therapy of chronic glomerulonephritis].
Ratner MIa; Tomilina NA; Biriukova LS; Monchakovskiĭ SF
Ter Arkh; 1985; 57(6):69-74. PubMed ID: 4071418
[TBL] [Abstract][Full Text] [Related]
32. [Urinary fibronectin as an indicator of kidney fibrosis in nephritis].
Kozlovskaia LV; Bobkova IN; Varshavskiĭ VA; Proskurneva EP; Miroshnichenko NG; Chebotareva NV; Mukhin NA
Ter Arkh; 1999; 71(6):34-8. PubMed ID: 10420453
[TBL] [Abstract][Full Text] [Related]
33. [Tests for cell membrane destabilization in assessing activity-progression of chronic glomerulonephritis].
Sigitova ON; Maksudova AN; Miasoutova LI
Ter Arkh; 2000; 72(6):26-30. PubMed ID: 10900644
[TBL] [Abstract][Full Text] [Related]
34. [Clinical varieties of chronic glomerulonephritis and psychic characteristics of patients].
Palamarchuk MI; Kukhtevich AV; Sokolova ED
Ter Arkh; 2002; 74(6):49-52. PubMed ID: 12136484
[TBL] [Abstract][Full Text] [Related]
35. Glomerular chemokine expression and the effect of steroid and cyclophosphamide pulse therapy in human crescentic glomerulonephritis.
Chen S; Liu Z; Chen H; Zhou H; Wang J; Li L
Chin Med J (Engl); 2002 Sep; 115(9):1301-7. PubMed ID: 12411099
[TBL] [Abstract][Full Text] [Related]
36. [Arterial hypertension in chronic glomerulonephritis: detectability and treatment efficacy].
Kutyrina IM; Martynov SA; Shvetsov MIu; Lifshits NL; Miroshnichenko NG; Golitsina EP; Varshavskiĭ VA
Ter Arkh; 2004; 76(9):10-5. PubMed ID: 15532369
[TBL] [Abstract][Full Text] [Related]
37. [Tubulointerstitial component of chronic glomerulonephritis. Clinico-morphological comparisons].
Tov NL; Valentik MF; Vakulin GM; Kagalovskaia IM; Sasin AV
Ter Arkh; 1985; 57(6):32-6. PubMed ID: 4071409
[TBL] [Abstract][Full Text] [Related]
38. [Blood phospholipids in patients with different clinical manifestations of chronic glomerulonephritis and preserved kidney function].
Riabov SI; Kulikova AI; Mitrofanova OV
Ter Arkh; 1995; 67(2):51-4. PubMed ID: 7725261
[No Abstract] [Full Text] [Related]
39. [Antistreptococcal antibodies in the blood serum of glomerulonephritis patients].
Nanchikeeva ML; Mukhin NA; Poliantseva LR; Kozlovskaia LV; Briko NI
Ter Arkh; 1992; 64(6):57-60. PubMed ID: 1440340
[TBL] [Abstract][Full Text] [Related]
40. [Subdivision of certain morphological variants of chronic glomerulonephritis].
Varshavskiĭ VA; Proskurneva EP; Gasanov AB; Severgina LO; Shestakova LA
Arkh Patol; 1999; 61(5):40-6. PubMed ID: 10598261
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
